Research areas

► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)

► Food and Drug Administration (FDA)

► technologies (e.g., drugs, devices, AI, cybersecurity)

Metholodogical approach

► guided by economic and sociological theory

► quantitative (statistical / econometric) methods

► large administrative, survey, and other datasets


Recent Activity

>> New Publication <<

March 7, 2025

Unregulated large language models produce medical device-like output. npj Digital Medicine 2025; 4:148.

>> New Publication <<

September 20, 2024

Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.

Public Comment

August 13, 2024

Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]


PricePod: Public Policy Conversations (podcast)

June 4, 2025

Closing the revolving door at HHS

Interview with Christian Hetrick

Cincinnati Enquirer

May 18, 2025

Nearly 60% of doctors take money from Big Pharma. Is your doctor one? [PDF]

by Elizabeth B. Kim